Related by context. All words. (Click for frequent words.) 65 LibiGel ® 64 LibiGel Phase III 63 BioSante 60 avanafil 60 elagolix 60 Elestrin 60 Proellex 60 NEBIDO 60 Zerenex 60 Menerba 59 Zelrix 59 bremelanotide 59 Plenaxis TM 59 Phase III LibiGel 59 Zoraxel 59 liprotamase 59 vilazodone 59 Marqibo 58 talactoferrin 58 Ophena TM 58 NDA submission 58 pivotal Phase III 58 PROVENGE 58 PREOS 58 LibiGel transdermal testosterone gel 58 alvimopan 58 QNEXA 58 Evamist TM 58 BioSante Pharmaceuticals 58 TOCOSOL Paclitaxel 58 picoplatin 58 Gabapentin GR 57 Phase IIb clinical 57 Androxal 57 bazedoxifene 57 dalbavancin 57 denufosol 57 ozarelix 57 Phenoptin 57 CoFactor 57 SILENOR TM 57 LibiGel testosterone gel 57 NP2 Enkephalin 57 rhThrombin 57 AeroLEF TM 57 Frova ® 56 Evamist 56 Phase 2b clinical 56 diabetic neuropathic pain 56 Sanctura XR 56 T Pred 56 Androxal ® 56 Anturol TM 56 Clonicel 56 oral ridaforolimus 56 pegloticase 56 Nasulin 56 NASDAQ BPAX 56 glufosfamide 56 Phase III clinical 56 Nebido 56 BYDUREON 56 Neurodex 56 Phase 2a trial 56 SILENOR 56 velafermin 56 Triolex 55 Phase 2b study 55 cetrorelix 55 EOquin 55 trospium 55 Adcirca 55 Bronchitol 55 Intrinsa 55 edoxaban 55 investigational compound 55 Phase III 55 Phase 1b 55 Bicifadine 55 AZILECT R 55 LibiGel ® testosterone gel 55 mipomersen 55 Anturol 55 RSD# oral 55 dapoxetine 55 MK #A [001] 55 Zelapar 55 Corlux 55 ospemifene 55 teduglutide 55 EFAPROXYN 55 eniluracil 55 Ketotransdel 55 vernakalant oral 55 Phase IIb trial 55 Ventavis 55 PROMACTA 54 CYCLOSET 54 Phase IIb 54 Pennsaid R 54 ZEGERID Capsules 54 oral prodrug 54 faropenem 54 elotuzumab 54 ONTAK 54 Vilazodone 54 Stedivaze 54 AeroLEF 54 RDEA# 54 tezampanel 54 Phase 1b trial 54 tesetaxel 54 Phase III pivotal 54 ustekinumab 54 Exalgo 54 Azedra 54 INCB# [002] 54 MAA submission 54 Phase IIa trial 54 confirmatory Phase 3 54 CR# vcMMAE 54 Q#IR 54 oral methylnaltrexone 54 Phase Ib 54 Naproxcinod 54 alogliptin 54 INC# 54 oral deforolimus 54 phase IIb clinical 54 Xibrom QD 54 Phase 2a clinical 54 Fortical R 54 Technosphere Insulin 54 ALTU 54 Phase IIIb clinical 54 Viramidine 54 INCB# [001] 54 Vernakalant 54 torezolid phosphate 54 Laquinimod 54 Tyvaso 54 PROVENGE sipuleucel T 54 Bepreve 54 Phase IIB 54 lomitapide 54 NUVIGIL 54 tesmilifene 54 MoxDuo IR 54 Mipomersen 54 Archexin 54 phase IIb 54 SPIRIVA HandiHaler 54 Phase 2a 54 RSD# 54 Alpharadin 54 arzoxifene 54 HspE7 53 Anturol ® 53 confirmatory Phase III 53 apaziquone 53 Ketotransdel TM 53 Sular formulation 53 Serdaxin 53 Androxal TM 53 Capesaris 53 Pimavanserin 53 ONCONASE 53 satraplatin 53 cangrelor 53 Aurexis 53 albinterferon alfa 2b 53 SUCCEED trial 53 JANUVIA 53 rNAPc2 53 Phase 2b trial 53 NGX# 53 SUPPRELIN R LA 53 fenofibric acid 53 Dr. Snabes 53 Synavive 53 Onsolis 53 Restanza 53 EVIZON 53 Diabetic Macular Edema 53 HuMax CD4 53 PEG PAL 53 CRMD# 53 registrational 53 rALLy trial 53 KRN# 53 oral anticoagulant 53 OvaRex ® MAb 53 Hyphanox 53 eltrombopag 53 MAGE A3 ASCI 53 Elagolix 53 oral rivaroxaban 53 Icatibant 53 ongoing Phase IIIb 53 Surfaxin LS 53 ZOLINZA 53 VIVUS 53 BEMA Buprenorphine 53 GALNS 53 Cellegesic 53 nalbuphine ER 53 belinostat 53 registrational trial 53 Dextofisopam 53 Asentar 53 PROPEL trial 53 alvespimycin 53 Probuphine 53 valopicitabine 53 TACI Ig 53 tanespimycin 53 PS# [001] 53 Kynapid 53 CCX# 53 Dapagliflozin 53 Tekamlo 53 unblinded 53 abiraterone acetate 53 Intermezzo R 53 Telavancin 53 Qnexa 53 AMR# 53 placebo controlled clinical 53 Dyloject TM 53 FOLOTYN 53 Civacir 53 ponatinib 53 TBC# 53 Serada 53 Omigard 53 Frova R 52 toremifene 52 lintuzumab 52 investigational drug 52 forodesine 52 GetGoal Phase III 52 FOLOTYN ® 52 Proxinium TM 52 methylnaltrexone 52 pseudobulbar affect PBA 52 KNS # 52 BLA submission 52 IoGen 52 Zenvia ™ 52 azficel T 52 Zingo TM 52 exenatide LAR 52 Phase III clinical trials 52 HuMax EGFr 52 XIAFLEX 52 Trexima 52 Rezular 52 BEMA TM Fentanyl 52 CIMZIA ™ 52 ARCOXIA 52 topical gel 52 oxymorphone ER 52 Bezielle 52 Dyloject 52 selective androgen receptor modulator 52 Acapodene 52 pivotal Phase 52 AZILECT ® 52 Zemplar Capsules 52 SinuNase 52 ToGA 52 Velac 52 PREGNANT Study 52 clinical trial 52 ITMN 52 Efficacy Results 52 ProSavin 52 APF# 52 oral calcitonin 52 Board DSMB 52 Ophena 52 Exenatide LAR 52 dose cohort 52 GTx 52 TMC# [002] 52 Zenvia 52 CRx 52 Pixuvri 52 Allovectin 7 R 52 Corautus 52 Eltrombopag 52 Fodosine 52 voreloxin 52 canakinumab 52 viral kinetic 52 LIALDA 52 maximally tolerated dose 52 IDX# 52 ISENTRESS 52 ruxolitinib 52 ganetespib 52 Panzem R NCD 52 Stelara 52 Inc. NASDAQ BPAX 52 romiplostim 52 BROMDAY 52 Apricus Bio 52 EOquin TM 52 Relovair 52 NVA# 52 Phase III trials 52 LymphoStat B 52 LY# [003] 52 Albuferon 52 adipiplon 52 daclizumab 52 Golimumab 52 Urocidin 52 DSMB 52 prodrug stimulant 52 opioid induced bowel dysfunction 52 phase IIa clinical 52 ISIS # 52 Empatic 52 ATryn R 52 Arcalyst 52 ELACYT 52 ALGRX 52 bicifadine 52 rivaroxaban 52 BST CarGel R 52 pralatrexate 52 Avanafil 52 IRX 2 52 Xinlay 52 Phase IIa clinical 52 SANCTURA XR 52 Elestrin TM 52 topical NSAID 52 EMBEDA ™ 52 OncoVEX GM CSF 52 faropenem medoxomil 52 TRILIPIX 52 Traficet EN 52 Strativa 52 EvaMist 52 Alzhemed TM 52 ostarine 52 Gralise 52 BLA filing 52 successfully commercialize Iluvien 52 refractory gout 52 MBP# [001] 52 LibiGel BioSante 52 oral taxane 52 anidulafungin 52 TELINTRA 52 ACUROX ® 52 IV APAP 51 tezampanel NGX# 51 orBec 51 PRX # 51 Myocet 51 LEVADEX 51 Regeneron Pharma 51 obatoclax 51 atacicept 51 PDE4 inhibitor 51 VA# [002] 51 Viprinex 51 Silodosin 51 denosumab 51 Exelon Patch 51 pradefovir 51 GATTEX 51 rilonacept 51 Emezine 51 tolerability profile 51 PEG INTRON 51 XmAb# 51 GLP toxicology studies 51 Biosante Pharmaceuticals 51 omacetaxine mepesuccinate 51 EmbraceAC 51 Amrubicin 51 Fortesta 51 PEG SN# 51 transdermal spray 51 Zensana TM 51 AFREZZA 51 ALKS 51 Amigal 51 R#/MEM # 51 Allovectin 7 ® 51 Tanespimycin 51 lixisenatide 51 aleglitazar 51 tolerability 51 StaphVAX 51 MONOVISC 51 Fablyn 51 PDUFA date 51 Genz # 51 QAB# 51 ofatumumab 51 Viibryd 51 Iluvien ® 51 LUVENIQ 51 octreotide implant 51 investigational pan BCR 51 Aegerion 51 BPAX 51 Imagify 51 ATHX 51 Raptiva ® 51 Viprinex TM 51 AEGR 51 Javelin Pharmaceuticals AMEX JAV 51 Ozarelix 51 aflibercept 51 romidepsin 51 Reverset 51 Nasdaq OPTR 51 peginesatide 51 vemurafenib 51 Levadex 51 phase IIb study 51 THALOMID 51 HCV protease inhibitor 51 PXD# 51 Fampridine SR 51 teriflunomide 51 budesonide foam 51 ELND# 51 LibiGel NDA 51 ocrelizumab 51 Zolinza 51 Phase 2b 51 Fibrillex TM 51 Egrifta 51 betrixaban 51 Firazyr 51 indiplon capsules 51 NPSP# 51 Panzem R 51 PRTX 51 Cellegy 51 Auxilium Pharmaceuticals 51 lasofoxifene 51 Darusentan 51 RE SURGE 51 ularitide 51 Agile Therapeutics 51 MEND CABG 51 Amoxicillin PULSYS 51 Abiraterone acetate 51 ataluren 51 TASKi2 51 BrachySil 51 Phase IIa trials 51 CORLUX 51 Pirfenidone 51 Chrysalin 51 BCX# 51 Emselex 51 riociguat 51 ACTEMRA TM 51 Enablex 51 zileuton CR 51 Ranexa 51 OMAPRO 51 RHUCIN 51 PHX# 51 ketoprofen patch 51 DU #b 51 Augment Bone Graft 51 Denosumab 51 Entereg 51 balsalazide tablet 51 Oracea 51 Krystexxa 51 phase 2a 51 efficacy endpoint 51 Oracea TM 51 vosaroxin 51 paliperidone palmitate 51 secondary efficacy endpoints 51 reslizumab 51 Sumavel DosePro 51 voclosporin 51 NATRECOR R 51 HuMax CD# 51 TASKi3 51 Enjuvia 51 MIRCERA 51 Chemophase 51 LUVOX CR 50 Daclizumab 50 APEX PD 50 Phase Ib clinical 50 LEVADEX ™ 50 desvenlafaxine 50 Acetavance 50 Pennsaid 50 Testim 50 regorafenib 50 velafermin belinostat 50 Troxatyl 50 Proellex TM 50 Iluvien 50 SPARLON 50 ZYBRESTAT 50 maraviroc 50 ONGLYZA 50 Contrave# 50 ATryn ® 50 Inhalation Solution 50 Phase Ib study 50 IPLEX 50 MAXY alpha 50 ixabepilone 50 evaluating tivozanib 50 fidaxomicin 50 Inc. NASDAQ AVNR 50 SCOLR Pharma 50 ThGRF 50 incyclinide 50 Azixa 50 NexMed 50 Bremelanotide 50 dirucotide 50 Tezampanel 50 LCP AtorFen 50 Pivotal Phase III 50 Fortigel 50 IL# PE#QQR 50 custirsen 50 Ceplene 50 darusentan 50 Onco TCS 50 Rexahn Pharmaceuticals 50 ILLUMINATE 50 lucinactant 50 Phase 2b clinical trials 50 LEUKINE 50 Phase Ia 50 MEND CABG II 50 ORENCIA ® 50 Hematide 50 AFRESA 50 BioMimetic 50 Phase III Pivotal 50 PLK1 SNALP 50 PENNSAID 50 MEK inhibitor RDEA# 50 indacaterol 50 JAK inhibitor 50 OncoGel 50 Onrigin 50 TOLAMBA 50 CANCIDAS 50 Aflibercept 50 Allovectin 7 50 placebo controlled Phase 50 Vivitrex 50 apremilast 50 FTY# 50 huC# DM4 50 roflumilast 50 SYMMETRY trial 50 Extina 50 Cardio Vascu Grow 50 Aclidinium 50 IND submission 50 Dacogen 50 Protexia R 50 STRIDE PD 50 ONGLYZA ™ 50 BAY #-# 50 pomalidomide 50 Orazol 50 AzaSite Plus 50 Trizytek 50 AVANDIA 50 severe hypercholesterolemia 50 Phase IIa 50 Avanir 50 midstage clinical 50 maribavir 50 Phase 1b clinical 50 ELADUR 50 Onbrez Breezhaler 50 pivotal bioequivalence 50 Genasense ® oblimersen 50 Riquent 50 Cladribine Tablets 50 sNDA submission 50 Elestrin TM estradiol gel 50 Octreolin 50 Prostate AdenoCarcinoma Treatment 50 sodium Injection 50 NKTR 50 GSK# [002] 50 Medidur FA 50 amrubicin 50 milnacipran 50 Relistor 50 CIP TRAMADOL ER 50 Aryplase 50 Vicriviroc 50 ridaforolimus 50 ISTA Pharmaceuticals 50 Harbor BioSciences 50 lubiprostone 50 ARIKACE 50 Varisolve 50 APEX AMI trial 50 phase IIb trial 50 Zalbin 50 dosing cohort 50 urocortin 2 50 exenatide 50 Zytiga 50 palifosfamide 50 ATL# [001] 50 panitumumab 50 Phase III Clinical Trials 50 Phase III HEAT 50 Juvista 50 NDA resubmission 50 Telaprevir 50 INCIVEK 50 PMA submission 50 AIMM trial 50 Tyrima 50 ApoB SNALP 50 Tocosol Paclitaxel 50 DDP# 50 Hsp# inhibitor 50 Sanctura 50 fostamatinib 50 oral formulation 50 bapineuzumab 50 Phase #/#a trial 50 ambrisentan 50 Zolpimist 50 XL# XL# XL# XL# 50 Gestiva TM 50 dexanabinol 50 Cethromycin 50 PhosLo 50 EpiCeram 50 Dasatinib 50 gabapentin enacarbil 50 OAB overactive bladder 50 MAP# 50 acyclovir Lauriad R 50 SNT MC# 50 Biologics License Application 50 AzaSite TM 50 perifosine 50 Climara Pro 50 IMA# 50 abiraterone 50 PREOS R 50 Hycamtin 50 YONDELIS 50 RSR# 50 Increlex ® 50 Phase Ib clinical trials 50 Dalbavancin 50 midstage trials 50 HZT 50 TachoSil 50 Tavocept 49 NASDAQ REGN 49 OvaRex R 49 Amplimexon 49 otelixizumab 49 SAR# [004] 49 Sulonex 49 NitroMist TM 49 telaprevir 49 SUMAVEL DosePro 49 VALSTAR 49 APTIVUS r 49 Sym# 49 pharmacokinetic PK 49 PEG Interferon lambda 49 Benlysta belimumab 49 Vicinium TM 49 Bionovo 49 Xcytrin R 49 T DM1 49 New Drug Application 49 BioSante Pharmaceuticals Inc. 49 Flutiform TM 49 FDA Approvable Letter 49 miconazole Lauriad R 49 omalizumab 49 Prolacria 49 ANCHOR trial 49 Safinamide 49 Complete Response 49 Zensana 49 Testosterone MDTS ® 49 clinical trials 49 EvaMist TM 49 Acrux 49 BEMA TM LA 49 Elestrin ™ estradiol gel 49 menopause contraception 49 PRT# 49 INKP 49 JZP 6 49 Medidur TM FA 49 Luveniq 49 deforolimus 49 Rajesh C. Shrotriya 49 orBec R 49 enzastaurin 49 pharmacokinetic PK study 49 NOXAFIL 49 RECOTHROM R 49 dacetuzumab 49 MacroChem 49 VIMOVO 49 Liraglutide 49 urate lowering 49 tivozanib 49 zalutumumab 49 alfimeprase 49 mg dose 49 Phase III Clinical Trial 49 topical formulation 49 ENRICH trial 49 Xanodyne 49 testosterone gel LibiGel 49 ramelteon 49 Cimzia TM 49 ITAX 49 EMBEDA 49 FM VP4 49 BENLYSTA 49 TYKERB 49 Ferumoxytol 49 Biologics License Application BLA 49 IV acetaminophen 49 OPT CHF 49 MOZOBIL 49 Phase 1a clinical 49 Transave 49 Genaera 49 SILENOR ™ 49 Ocrelizumab 49 SPIRIT IV 49 Heplisav 49 FACTIVE R gemifloxacin 49 linaclotide 49 Lidoderm R 49 PRISTIQ 49 Ramelteon 49 Cutanea Life Sciences 49 Topical Interferon Alpha 2b 49 Orapred ODT 49 ESTRASORB 49 CINTREDEKIN BESUDOTOX 49 MyVax 49 Northera 49 Vaprisol 49 AEG# 49 Eliquis 49 atrasentan 49 REOLYSIN ® 49 NicVAX 49 CINQUIL 49 visilizumab 49 Pliaglis 49 oral salmon calcitonin 49 Vidaza 49 Theravance 49 aclidinium 49 MDV# 49 Taxotere ® 49 randomized Phase IIb 49 Pivotal Clinical Trial 49 ZEGERID Powder 49 molecular entities NMEs 49 PRECISE Trial 49 Lorcaserin 49 Degarelix 49 Phase 2b Clinical Trial 49 FOSRENOL 49 vismodegib 49 Phase 1b dose escalation 49 Dificid 49 Phase #b/#a clinical 49 vicriviroc 49 Cinryze TM 49 Tarceva TM 49 TriRima 49 Zenvia Phase III 49 AZX# 49 pramlintide 49 raloxifene Evista 49 Ampyra 49 CDP# 49 Memryte 49 TELCYTA 49 BRIM2 49 delivers fluocinolone acetonide FA 49 CCR9 antagonist 49 asenapine 49 REVLIMID lenalidomide 49 NASDAQ OPTR 49 TYGACIL 49 CA4P 49 subcutaneously administered 49 GENR 49 baminercept 49 Celgene Revlimid 49 EVIZON TM squalamine lactate 49 Adentri 49 postoperative ileus POI 49 AzaSite 49 unblind 49 metaglidasen 49 Apixaban 49 Xyotax 49 Urocortin 2 49 LymphoStat B TM 49 Dendreon Provenge 49 oral hydromorphone 49 Ardea Biosciences 49 MyVax R 49 rALLy clinical trial 49 Afresa 49 Treximet 49 NovaDel 49 virus HCV protease inhibitor 49 BioDelivery Sciences 49 Syncria 49 afatinib 49 octreotide acetate 49 phase IIa 49 BENLYSTA ® 49 TRANSDUR Sufentanil 49 Glybera R 49 Glufosfamide 49 rasagiline tablets 49 sapacitabine 49 QLT# 49 naproxcinod 49 Cetrorelix 49 XenoPort 49 Onrigin TM 49 QVA# 49 Phase #b/#a 48 varespladib 48 Replidyne 48 SARMs 48 nab paclitaxel 48 XIBROM 48 trastuzumab DM1 48 Intellipharmaceutics 48 CLARITY study 48 selective androgen receptor modulators 48 Corcept 48 Bydureon 48 Diamyd ® 48 Tesetaxel 48 ASA# 48 Ereska 48 COMFORT II 48 Horizant 48 L BLP# 48 Phase #b/#a trial 48 Palatin Technologies 48 Virulizin R 48 ESTRASORB R 48 Xgeva 48 IMGN# 48 mertansine 48 LymphoStat B belimumab 48 ENDEAVOR III 48 include LibiGel ® 48 NDA Submission 48 ALVESCO HFA 48 Welchol 48 Anika Therapeutics 48 abatacept 48 intravenous acetaminophen 48 midstage study 48 postoperative ileus 48 NO# [002] 48 multicenter Phase III 48 Puricase 48 HER2 positive metastatic breast 48 VitiGam 48 AZOR 48 Pharmasset 48 metastatic sarcomas 48 Belinostat 48 isavuconazole 48 MERLIN TIMI 48 eprotirome 48 Intermezzo ® 48 pertuzumab 48 nitazoxanide 48 #mg dose [003] 48 oxybutynin ATD TM 48 Ostarine 48 Durect 48 Rivaroxaban 48 L MTP PE 48 sorafenib tablets 48 almorexant 48 QuatRx 48 hypoparathyroidism 48 Simulect 48 Loramyc R 48 PROVENGE ® 48 Panzem 48 relapsed multiple myeloma 48 CorMedix 48 ALN PCS 48 anticancer compound 48 Personalized Immunotherapy 48 Gestiva 48 telcagepant 48 leading oral taxane 48 SCOLR 48 Amitiza 48 vinorelbine 48 Zerenex ™ 48 ONCONASE R 48 Prestara 48 VEGF Trap 48 Halozyme 48 thorough QT 48 Clolar 48 ACOMPLIA R 48 BRILINTA 48 MethyPatch 48 Indevus 48 diarrhea predominant irritable 48 AVNR 48 FDA approvable letter 48 iclaprim 48 Esbriet 48 Dr. Fahar Merchant 48 Achieves Primary Endpoint 48 Celacade TM technology 48 QRxPharma 48 Clevudine 48 initiated Phase 1b 48 Phase Ib II 48 Urigen 48 Exelbine 48 ferumoxytol Injection 48 YERVOY 48 SinuNase TM 48 trastuzumab emtansine T DM1 48 Stavzor 48 EDEMA4 48 selegiline 48 VELCADE 48 Vandetanib 48 VYVANSE 48 Victoza ® 48 Ticagrelor 48 telbivudine 48 microplasmin 48 danoprevir 48 Phase 2b Trial 48 Exforge 48 Pafuramidine 48 ZYFLO CR 48 Flutiform ™ 48 VPRIV 48 celgosivir 48 ADVENTRX 48 BAL# [002] 48 Folotyn 48 Ambrisentan 48 PSMA ADC 48 ARYx 48 XiDay 48 EDEMA3 48 ATL/TV# 48 BZL# 48 FermaVir 48 Locteron ® 48 linagliptin 48 Inc. Nasdaq VVUS 48 Zenpep 48 GEM OS1 48 Satraplatin 48 Soriatane